5 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill

3. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 79

Pfizer Inc. (NYSE:PFE) is a major healthcare company selling biopharmaceutical products globally. The company offers medicines and vaccines in several therapeutic areas such as immunotherapies, biologics, and small molecules.

The blood-thinner Eliquis is a shared product between Pfizer Inc. (NYSE:PFE) and Bristol-Myers Squibb Company (NYSE:BMY). Hence the loss of patent exclusivity for the drug, which may come about by 2026, is set to harm Pfizer Inc. (NYSE:PFE) as well.

In August, Carter Gould at Barclays reiterated an ‘Equal Weight’ rating on Pfizer Inc. (NYSE:PFE) shares. Gould also placed a $52 price target on the shares. Out of 912 hedge funds that filed 13Fs for Q1, 79 funds held stakes in Pfizer Inc. (NYSE:PFE) in the first quarter, which had a total value of $4.1 billion.